- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06847815
Glycemic Index of Sweet Corn
March 25, 2026 updated by: University of Florida
Determination of the Glycemic Index of Differently Processed Sweet Corn
Processing sweet corn may impact digestibility and, therefore, glycemic response following consumption.
The primary aim of this study is to assess the glycemic index of various sweet corn products and varieties.
An exploratory aim is to assess hunger/satiety scores following sweet corn intake.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
Gainesville, Florida, United States, 32611
- Food Science and Human Nutrition Building
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Able to provide written consent in English
- Willing to consume 50 g of glucose in less than 15 minutes (2 mornings)
- Willing to consume around 250 to 350 g of sweet corn in 10 to 15 minutes (3 mornings)
- Willing to provide 7 capillary blood samples by fingerstick (by fine lancet) during each 2-hour session
Exclusion Criteria:
- Metabolic disease or condition affecting blood glucose, such as diabetes type 1 and 2, metabolic syndrome, or polycystic ovary syndrome
- Baseline fasting blood glucose > 100 mg/dL
- Currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Glucose Tolerance Drink
50 g glucose beverage
|
Beverage providing 50 g of glucose
|
|
Experimental: Sweet corn
Sweet corn providing 50 g of available carbohydrate
|
Fresh and processed sweet corn
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
iAUC
Time Frame: From enrollment to the end of 5 weeks.
|
Incremental area under the glycemic response curve (iAUC)
|
From enrollment to the end of 5 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hunger and Satiety Score
Time Frame: From enrollment to the end of 5 weeks.
|
Hunger and Satiety Visual Analogue Scale from 0 to 100 mm (higher number indicates increased hunger, satisfaction, fullness, and eating perception)
|
From enrollment to the end of 5 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 5, 2025
Primary Completion (Actual)
June 17, 2025
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
February 21, 2025
First Submitted That Met QC Criteria
February 21, 2025
First Posted (Actual)
February 26, 2025
Study Record Updates
Last Update Posted (Actual)
March 31, 2026
Last Update Submitted That Met QC Criteria
March 25, 2026
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB202500171
- 2022-51181-38333 (Other Grant/Funding Number: US DEPT OF AG NATL INST OF FOOD AND AG)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Index
-
Rehman Medical Institute - RMINot yet recruitingGlycemic Index and Glycemic LoadPakistan
-
Rehman Medical Institute - RMINot yet recruitingGlycemic Index | Glycemic Load
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
PepsiCo Global R&DCompletedGlycemic IndexUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Rehman Medical Institute - RMINot yet recruitingGlycemic Index and Glycemic Load
-
Aga Khan UniversityUnknown
-
Azienda di Servizi alla Persona di PaviaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Nutrition Institute, SloveniaValens Int. d.o.o., SlovenijaCompleted
Clinical Trials on Glucose Tolerance Drink
-
Mednax Center for Research, Education, Quality...Banner University Medical CenterTerminated
-
University of FloridaCompletedDrug Induced Hyperglycemia | Secondary HyperlipidemiaUnited States
-
University of LausanneCompleted
-
NYU Langone HealthCompletedGlucose Metabolism Disorders | Diabetes Mellitus | Prediabetic State | Diabetes, GestationalUnited States
-
Universität des SaarlandesCompleted
-
Imperial College LondonTerminated
-
University Hospital, CaenCompleted
-
The University of Hong KongQueen Mary Hospital, Hong KongUnknown
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States